Corporate Consortium Program

In order to leverage additional sources of capital and maximize support for its portfolio companies, MLSC has developed a Corporate Consortium Program for corporate and investment partners to contribute matching funds for MLSC's activities. Through a suite of initiatives, MLSC will identify and make funds available to early-stage life sciences companies with a high-potential for commercialization, rapid growth, and downstream institutional financing. Johnson & Johnson has signed on as the charter member of the Consortium, and the Center is approaching other potential partners as well. Learn more about the launch of the Corporate Consortium Program here.

For additional information, or to express interest in joining the Corporate Consortium Program, please contact:
Luis Barros at lbarros@masslifesciences.com.